The role of busulfan/cyclophosphamide regimens in allogeneic and autologous bone marrow transplantation.
Brodsky
I
I
Department of Neoplastic Diseases, Hahnemann University, Philadelphia, Pennsylvania.
Bulova
S
S
Crilley
P
P
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D051379:Mice; D051381:Rats; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D003520:Cyclophosphamide; D002066:Busulfan